Skip to main content
. 2024 Jan 15;12(1):183. doi: 10.3390/biomedicines12010183
ACS American Cancer Society
AMPK Adenosine Monophosphate-activated Protein Kinase
ARSI Androgen Receptor Signaling Inhibitor
BCRT Breast Cancer C-terminal Domains
CSC Cancer Stem Cell
CAR Chimeric Antigen Receptor
COX Cyclooxygenase
CPZ Chlorpromazine
DDP Diamminedichloroplatinum
DHFR Dihydrofolate Reductase
DOX Doxorubicin
ER Estrogen Receptor
FLICE FADD-like IL-1β-converting Enzyme
HER2 Human Epidermal growth factor Receptor-related protein (HER2)
HIF Hypoxia-inducible Factor
IAPs Inhibitors of Apoptosis Proteins
iDNMT DNA Methylation Inhibitors
IHC Immunohistochemical
iHDACs Histone Deacetylase Inhibitors
JNK Jun N-terminal Kinase
MBZ Mebendazole
MDM2 Murine Double Minute 2
MDR Multidrug Resistance
MRP Multidrug Resistance Protein
MTX Methotrexate
PEI Polyethyleneimine
PEO Polyethylene Oxide
PET Positron Emission Tomography
PHD Prolyl Hydroxylase Domain
PLGA Poly lactic-co-glycolic acid
PR Progesterone Receptor
PTM Posttranscriptional Modifications
RCC Renal Cell Carcinoma
RES Reticuloendothelial system
RFC Reduced Folate Carrier
TAM Tumor-associated Macrophages
TCTP Translationally Controlled Tumor Protein
TME Tumor Microenvironment
TRAIL Tumor necrosis factor-Related Apoptosis-Inducing Ligand
TS Thymidylate Synthase
VEGF Vascular Endothelial Growth Factor